N Schluger, C Ciotoli, D Cohen, H Johnson and WN Rom
Bellevue Chest Service, New York University Medical Center, New York, USA.

The current tuberculosis epidemic in the United States is marked, in many areas, by high rates of noncompliance with antituberculous regimens. In response to this, a comprehensive program of medical, nursing, social services, and supervised therapy was developed at Bellevue Hospital. Most patients were referred to the on-site directly observed therapy program (DOT) located in the hospital. Patients on DOT received daily or twice weekly therapy, and were given incentives to enhance compliance. Outreach was used to track patients who missed appointments. From November 1992 through July 1993, 113 patients were referred. HIV infection, homelessness, illicit drug use, and alcoholism were common. Follow-up revealed that 11 patients were noncompliant and completely lost to follow-up; of the remaining 102, 99% achieved bacteriologic cure. Of the 102 patients who received therapy, 74 attended the Bellevue DOT clinic, 16 attended other DOT programs in the city or received medication at home, and three died of HIV-related, nontuberculous illness. Nine patients were self-medicated and judged treatment successes. We conclude that a comprehensive hospital-based tuberculosis control program is capable of achieving a high degree of success, even in a population at high risk for noncompliance.

This article has been cited by other articles:

				T. Bandyopadhyay, H. Murray, and M. L. Metersky Cost-effectiveness of Tuberculosis Prophylaxis After Release From Short-term Correctional Facilities* Chest, June 1, 2002; 121(6): 1771 - 1775. [Abstract] [Full Text] [PDF]

				M. Bashar, P. Alcabes, W. N. Rom, and R. Condos Increased Incidence of Multidrug-Resistant Tuberculosis in Diabetic Patients on the Bellevue Chest Service, 1987 to 1997 Chest, November 1, 2001; 120(5): 1514 - 1519. [Abstract] [Full Text] [PDF]

				H. Sanchez-Perez, J. Flores-Hernandez, J. Jansa, J. Cayla, and M Martin-Mateo Pulmonary tuberculosis and associated factors in areas of high levels of poverty in Chiapas, Mexico Int. J. Epidemiol., April 1, 2001; 30(2): 386 - 393. [Abstract] [Full Text] [PDF]

				S. W. Hwang Homelessness and health Can. Med. Assoc. J., January 1, 2001; 164(2): 229 - 233. [Abstract] [Full Text] [PDF]

				J. M. FitzGerald, L. Wang, and R. K. Elwood Tuberculosis: 13. Control of the disease among aboriginal people in Canada Can. Med. Assoc. J., February 1, 2000; 162(3): 351 - 355. [Abstract] [Full Text] [PDF]

				D. C. SNYDER and D. P. CHIN Cost-effectiveness Analysis of Directly Observed Therapy for Patients with Tuberculosis at Low Risk for Treatment Default Am. J. Respir. Crit. Care Med., August 1, 1999; 160(2): 582 - 586. [Abstract] [Full Text]

				J. M. FitzGerald and S. Houston Tuberculosis: 8. The disease in association with HIV infection Can. Med. Assoc. J., July 1, 1999; 161(1): 47 - 51. [Abstract] [Full Text] [PDF]

				Joint Tuberculosis Committee of the British Thorac Chemotherapy and management of tuberculosis in the United Kingdom: recommendations 1998 Thorax, July 1, 1998; 53(7): 536 - 548. [Abstract] [Full Text]

				C. P. Chaulk, V. A. Kazandjian, and for the Public Health Tuberculosis Guidelines Pane Directly Observed Therapy for Treatment Completion of Pulmonary Tuberculosis: Consensus Statement of the Public Health Tuberculosis Guidelines Panel JAMA, March 25, 1998; 279(12): 943 - 948. [Abstract] [Full Text] [PDF]

				I. Bamforth, H J Milburn, and G M Cochrane Compliance and concordance with treatment BMJ, June 28, 1997; 314(7098): 1905 - 1905. [Full Text]